Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage

被引：0
|
作者：
Edwin Uriel Suárez
Miguel Ángel Piris
Socorro María Rodríguez-Pinilla
Juan F. García
José Luis López-Lorenzo
Javier Cornago-Navascués
Rocío Salgado-Sánchez
Tamara Castaño-Bonilla
Raquel Mata-Serna
Juan M. Alonso-Domínguez
Pilar Llamas
机构：
[1] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Hematology
[2] Universidad Autónoma de Madrid,Department of Pathology
[3] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Pathology
[4] Universidad Autónoma de Madrid,undefined
[5] MD Anderson Cancer Center,undefined
来源：
Annals of Hematology | 2024年 / 103卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1797 / 1799
页数：2
相关论文
共 50 条
  • [1] Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage
    Suarez, Edwin Uriel
    Piris, Miguel angel
    Rodriguez-Pinilla, Socorro Maria
    Garcia, Juan F.
    Lopez-Lorenzo, Jose Luis
    Cornago-Navascues, Javier
    Salgado-Sanchez, Rocio
    Castano-Bonilla, Tamara
    Mata-Serna, Raquel
    Alonso-Dominguez, Juan M.
    Llamas, Pilar
    ANNALS OF HEMATOLOGY, 2024, 103 (05) : 1797 - 1799
  • [2] BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia
    He, Rong
    Greipp, Patricia T.
    Rangan, Aruna
    Mai, Ming
    Chen, Dong
    Reichard, Kaaren K.
    Nelsen, Laura L.
    Pardanani, Animesh
    Hanson, Curtis A.
    Viswanatha, David S.
    CANCER GENETICS, 2016, 209 (05) : 223 - 228
  • [3] Clonal Competition Between JAK2 and BCR-ABL in Myeloproliferative Neoplasm
    Salk, Gabriel
    Mangala, Yashvin Onkarappa
    Onukogu, Ifeanyichukwu David
    Meleveedu, Kapil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S384 - S384
  • [4] Update on JAK2 inhibitors in myeloproliferative neoplasm
    Chan, Daniel
    Koren-Michowitz, Maya
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (02) : 61 - 71
  • [5] BCR-JAK2 gene fusion drives a myeloproliferative neoplasm in transplanted mice
    Cuesta-Dominguez, A.
    Ortega, M.
    Leon-Rico, D.
    Santos-Roncero, M.
    Alvarez, L.
    Martin-Rey, M. A.
    Almarza, E.
    Bueren, J.
    Rio, P.
    Fernandez-Ruiz, E.
    HUMAN GENE THERAPY, 2013, 24 (12) : A160 - A161
  • [6] Chronic Myeloproliferative Neoplasm with Concurrent BCR-ABL Trans location and JAK2 Mutation
    Siddiqui, Nauman Saleem
    Ssiddiqui, Haroon Saleem
    Dr Qurat-ul-Ain
    Siddiqui, Saleem Ahmad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (06): : 423 - 423
  • [7] Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm
    Chen, Z.
    Wang, W.
    Verstovsek, S.
    Cortes, J. E.
    Medeiros, L. J.
    Hu, S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (06) : E150 - E152
  • [8] BCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice
    Cuesta-Dominguez, Alvaro
    Leon-Rico, Diego
    Alvarez, Lara
    Diez, Begona
    Bodega-Mayor, Irene
    Banos, Rocio
    Angel Martin-Rey, Miguel
    Santos-Roncero, Matilde
    Luisa Gaspar, Maria
    Martin-Acosta, Paloma
    Almarza, Elena
    Bueren, Juan A.
    Rio, Paula
    Fernandez-Ruiz, Elena
    JOURNAL OF PATHOLOGY, 2015, 236 (02): : 219 - 228
  • [9] DUSP6 Mediates Resistance to JAK2 Inhibition and Drives Myeloproliferative Neoplasm Disease Progression
    Kong, Tim
    Laranjeira, Angelo B. A.
    Yang, Kangning
    Fisher, Daniel A. C.
    Yu, La Yow
    Wang, Anthony Z.
    Ruzinova, Marianna B.
    Fowles, Jared S.
    Allen, Maggie J.
    Celik, Hamza
    Challen, Grant A.
    Huang, Sidong
    Oh, Stephen T.
    BLOOD, 2021, 138
  • [10] The myeloproliferative neoplasm-associated JAK2 46/1 haplotype is not overrepresented in chronic myelogenous leukemia
    Spolverini, Ambra
    Jones, Amy V.
    Hochhaus, Andreas
    Pieri, Lisa
    Cross, Nicholas C. P.
    Vannucchi, Alessandro M.
    ANNALS OF HEMATOLOGY, 2011, 90 (03) : 365 - 366
12345